Feng‐Qiang Yang

996 total citations
23 papers, 831 citations indexed

About

Feng‐Qiang Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Feng‐Qiang Yang has authored 23 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Feng‐Qiang Yang's work include Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (6 papers) and Epigenetics and DNA Methylation (4 papers). Feng‐Qiang Yang is often cited by papers focused on Circular RNAs in diseases (6 papers), Cancer-related molecular mechanisms research (6 papers) and Epigenetics and DNA Methylation (4 papers). Feng‐Qiang Yang collaborates with scholars based in China and United States. Feng‐Qiang Yang's co-authors include Jian‐Ping Che, Junhua Zheng, Haimin Zhang, Chen Shao-jun, Min Liu, Junhua Zheng, Guangchun Wang, Wei Li, Junhua Zheng and Jianhua Huang and has published in prestigious journals such as PLoS ONE, Journal of Cellular Physiology and Theranostics.

In The Last Decade

Feng‐Qiang Yang

23 papers receiving 828 citations

Peers

Feng‐Qiang Yang
Yanmei Yi China
Bing Wei China
Yingkun Xu China
Zhongqiang Guo China
Zhiwei Zhou China
Zhiqing Fang China
Ricardo Marques Portugal
Seher Balaban Australia
Yanmei Yi China
Feng‐Qiang Yang
Citations per year, relative to Feng‐Qiang Yang Feng‐Qiang Yang (= 1×) peers Yanmei Yi

Countries citing papers authored by Feng‐Qiang Yang

Since Specialization
Citations

This map shows the geographic impact of Feng‐Qiang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Qiang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Qiang Yang more than expected).

Fields of papers citing papers by Feng‐Qiang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng‐Qiang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Qiang Yang. The network helps show where Feng‐Qiang Yang may publish in the future.

Co-authorship network of co-authors of Feng‐Qiang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Feng‐Qiang Yang. A scholar is included among the top collaborators of Feng‐Qiang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng‐Qiang Yang. Feng‐Qiang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wei, Feng‐Qiang Yang, Jianhua Huang, et al.. (2020). circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma. Theranostics. 10(10). 4395–4409. 69 indexed citations
2.
Wang, Jie, et al.. (2020). Circular RNA DHX33 promotes malignant behavior in ccRCC by targeting miR-489-3p/MEK1 axis. Aging. 12(14). 14885–14896. 18 indexed citations
3.
Hong, Hong, et al.. (2019). Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer. Molecular Medicine Reports. 19(6). 4761–4769. 21 indexed citations
4.
Yang, Feng‐Qiang, et al.. (2018). HOXA11‐AS promotes the growth and invasion of renal cancer by sponging miR‐146b‐5p to upregulate MMP16 expression. Journal of Cellular Physiology. 233(12). 9611–9619. 48 indexed citations
5.
Yang, Feng‐Qiang, et al.. (2015). MiR-506 Is Down-Regulated in Clear Cell Renal Cell Carcinoma and Inhibits Cell Growth and Metastasis via Targeting FLOT1. PLoS ONE. 10(3). e0120258–e0120258. 60 indexed citations
6.
Xue, Sheng, et al.. (2015). Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.. PubMed. 8(4). 3765–74. 45 indexed citations
7.
Yang, Feng‐Qiang, Haimin Zhang, Jun Li, et al.. (2014). Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.. PubMed. 7(7). 4231–8. 14 indexed citations
8.
Yang, Yan, Feng‐Qiang Yang, Haimin Zhang, Jian‐Ping Che, & Junhua Zheng. (2014). Up-regulation of flotillin-2 is associated with renal cell carcinoma progression. Tumor Biology. 35(10). 10479–10486. 23 indexed citations
9.
Zhang, Haimin, Feng‐Qiang Yang, Chen Shao-jun, Jian‐Ping Che, & Junhua Zheng. (2014). Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumor Biology. 36(4). 2947–2955. 191 indexed citations
10.
Yang, Feng‐Qiang, Min Liu, Fengping Yang, et al.. (2014). VPA inhibits renal cancer cell migration by targeting HDAC2 and down-regulating HIF-1α. Molecular Biology Reports. 41(3). 1511–1518. 23 indexed citations
11.
Yang, Feng‐Qiang, et al.. (2014). Combination of quercetin and hyperoside inhibits prostate cancer cell growth and metastasis via regulation of microRNA-21. Molecular Medicine Reports. 11(2). 1085–1092. 63 indexed citations
12.
Yang, Feng‐Qiang, Min Liu, Fuquan Yang, et al.. (2014). Matrix metallopeptidase 2 (MMP2) media la eliminación de MHC class I polypeptide-related sequence A (MICA) en el cáncer de células renales. Actas Urológicas Españolas. 38(3). 172–178. 15 indexed citations
13.
Yang, Feng‐Qiang, Jianhua Huang, Wei Li, et al.. (2014). Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells.. PubMed. 7(10). 3289–96. 21 indexed citations
14.
Yang, Feng‐Qiang, Jianhua Huang, Min Liu, et al.. (2014). Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder.. PubMed. 7(1). 340–7. 22 indexed citations
15.
Yang, Feng‐Qiang, Fengping Yang, Wěi Li, et al.. (2014). Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.. PubMed. 7(1). 110–22. 26 indexed citations
16.
Yang, Feng‐Qiang, Min Liu, Fuquan Yang, et al.. (2014). Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma. Actas Urológicas Españolas (English Edition). 38(3). 172–178. 12 indexed citations
17.
18.
Yang, Feng‐Qiang, et al.. (2013). GATA-3 es subregulado en pacientes con carcinoma renal de células claras. Actas Urológicas Españolas. 37(8). 489–497. 2 indexed citations
19.
Yang, Feng‐Qiang, Yang Shao, Fengping Yang, et al.. (2013). Valproic acid upregulates NKG2D ligand expression and enhances susceptibility of human renal carcinoma cells to NK cell-mediated cytotoxicity. Archives of Medical Science. 2(2). 323–331. 21 indexed citations
20.
Liu, Min, Yunfei Xu, Yuan Feng, et al.. (2012). Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors. Journal of Surgical Research. 183(1). 397–404. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanmei Yi Breakdown of academic impact, for papers by Bing Wei Breakdown of academic impact, for papers by Yingkun Xu Breakdown of academic impact, for papers by Zhongqiang Guo Breakdown of academic impact, for papers by Zhiwei Zhou Breakdown of academic impact, for papers by Zhiqing Fang Breakdown of academic impact, for papers by Ricardo Marques Breakdown of academic impact, for papers by Seher Balaban
Rankless by CCL
2026